Cardiomyopathies and Arrhythmias Induced by Cancer Therapies

Biomedicines
Dragoș-Mihai RomitanTudor-Eliade Ciuleanu

Abstract

Cardiology and oncology are two fields dedicated to the study of various types of oncological and cardiac diseases, but when they collide, a new specialty is born, i.e., cardio-oncology. Continuous research on cancer therapy has brought into the clinic novel therapeutics that have significantly improved patient survival. However, these therapies have also been associated with adverse effects that can impede the proper management of oncological patients through the necessity of drug discontinuation due to life-threatening or long-term morbidity risks. Cardiovascular toxicity from oncological therapies is the main issue that needs to be solved. Proper knowledge, interpretation, and management of new drugs are key elements for developing the best therapeutic strategies for oncological patients. Upon continuous investigations, the profile of cardiotoxicity events has been enlarged with the inclusion of myocarditis upon administration of immune checkpoint inhibitors and cardiac dysfunction in the context of cytokine release syndrome with chimeric antigen receptor T cell therapy. Affinity enhanced and chimeric antigen receptor T cells have both been associated with hypotension, arrhythmia, and left ventricular dysfunction, typically ...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P CarterH M Shepard
Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E K RowinskyR C Donehower
May 1, 1993·International Journal of Cardiology·F OrzanL Libero
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Oct 6, 2001·The New England Journal of Medicine·J A de LemosE Braunwald
Oct 3, 2002·Current Opinion in Critical Care·Sreenandh KrishnagopalanAnand Kumar
Jan 19, 2006·Cancer Chemotherapy and Pharmacology·Søren Astrup Jensen, Jens Benn Sørensen
May 30, 2006·European Heart Journal·Saher HamedJacob George
Jul 25, 2006·Nature Medicine·Risto KerkeläThomas Force
Jul 27, 2006·Human & Experimental Toxicology·P TsibiribiQ Timour
May 29, 2007·Microvascular Research·Arindel S R Maharaj, Patricia A D'Amore
Oct 17, 2007·Genes & Development·Anil K Rustgi
Dec 7, 2007·The Journal of Clinical Investigation·Sizhi Paul GaoJacqueline F Bromberg
May 23, 2008·Leukemia Research·Antonio Luiz RibeiroNelma C D Clementino
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca GianniDouglas B Sawyer
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hui-Wen LoFrancis Ali-Osman
Jan 13, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Mark FreilichFranklin Rosenfeldt
Mar 21, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Monica GianniEva Lonn
Apr 10, 2009·The New England Journal of Medicine·Leslie T Cooper
Feb 25, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Richard A MorganSteven A Rosenberg
Aug 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniela CardinaleCarlo M Cipolla
Feb 1, 2011·Pharmacotherapy·Cécile BasselinQuadiri Timour
Apr 14, 2011·Heart·Declan P O'Regan, Stuart A Cook
May 4, 2011·Clinical Cardiology·Victor FelizMaya Guglin
Jun 2, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Kostas N SyrigosKevin Harrington
Sep 3, 2011·Circulation Research·Elizabeth Murphy
Sep 15, 2011·Circulation. Heart Failure·Yujie WangGang Hu
Nov 5, 2011·Proceedings of the American Thoracic Society·Alon Lazarus, Eli Keshet
Dec 8, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael R GrunwaldLuis Alberto Diaz
Dec 14, 2011·The New England Journal of Medicine·José BaselgaUNKNOWN CLEOPATRA Study Group
Feb 10, 2012·JAMA : the Journal of the American Medical Association·Willemien van de WaterStephen E Jones
Mar 20, 2012·Antioxidants & Redox Signaling·Angelica M MerlotDes R Richardson
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll

❮ Previous
Next ❯

Citations

May 15, 2021·Frontiers in Cardiovascular Medicine·Andrew J Smith

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging technique
X-ray

Software Mentioned

SPRINT

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.